Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Protzer

Showing results (211-220 of 308) with videos related to

Pageof 31
Sort By:
JHEP Reports : Innovation in Hepatology|January 30, 2023
Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune toleranceJulia Sacherl, Anna D Kosinska, Kristina Kemter, et al.
Frontiers in Immunology|May 7, 2024
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cellsSophia Schreiber, Lisa S Dressler, Eva Loffredo-Verde, et al.
Plos One|May 8, 2014
Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatinAndrea Wuestenberg, Janine Kah, Katrin Singethan, et al.
Cellular Microbiology|November 3, 2021
Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membraneLili Zhao, Fuwang Chen, Oliver Quitt, et al.
Vaccines|August 29, 2024
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine ResponseKrischan Braitsch, Samuel D Jeske, Jacob Stroh, et al.
Frontiers in Immunology|September 26, 2022
Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severityJulius Nückel, Elisa Planatscher, Anne Wiebe Mohr, et al.
Antiviral Research|November 14, 2021
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion proteinHristo L Svilenov, Julia Sacherl, Alwin Reiter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantationUlrike Protzer, Friederike Böhm, Thomas Longerich, et al.
Frontiers in Immunology|March 30, 2026
Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody responseHélène A Kerth, Martin Kächele, Nikolas Müller, et al.
The Journal of Biological Chemistry|December 10, 2009
Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intoleranceBéatrice Bailly-Maitre, Bengt F Belgardt, Sabine D Jordan, et al.
Pageof 31

Showing results (211-220 of 308) with videos related to

Sort By:
Pageof 31
JHEP Reports : Innovation in Hepatology|January 30, 2023
Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune toleranceJulia Sacherl, Anna D Kosinska, Kristina Kemter, et al.
Frontiers in Immunology|May 7, 2024
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cellsSophia Schreiber, Lisa S Dressler, Eva Loffredo-Verde, et al.
Plos One|May 8, 2014
Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatinAndrea Wuestenberg, Janine Kah, Katrin Singethan, et al.
Cellular Microbiology|November 3, 2021
Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membraneLili Zhao, Fuwang Chen, Oliver Quitt, et al.
Vaccines|August 29, 2024
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine ResponseKrischan Braitsch, Samuel D Jeske, Jacob Stroh, et al.
Frontiers in Immunology|September 26, 2022
Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severityJulius Nückel, Elisa Planatscher, Anne Wiebe Mohr, et al.
Antiviral Research|November 14, 2021
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion proteinHristo L Svilenov, Julia Sacherl, Alwin Reiter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantationUlrike Protzer, Friederike Böhm, Thomas Longerich, et al.
Frontiers in Immunology|March 30, 2026
Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody responseHélène A Kerth, Martin Kächele, Nikolas Müller, et al.
The Journal of Biological Chemistry|December 10, 2009
Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intoleranceBéatrice Bailly-Maitre, Bengt F Belgardt, Sabine D Jordan, et al.
Pageof 31